Phibro Animal Health | PAHC - Net Income


Phibro Animal Health reported $27.46M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Align Technology USD 135.76M 79.01M Dec/2025
ANI Pharmaceuticals USD 32.35M 6.08M Dec/2025
Assertio Holdings USD -2.92M 753K Sep/2024
Aurora Cannabis CAD 1.82M 53.29M Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Canopy Growth CAD -62.63M 60.99M Dec/2025
Corcept Therapeutics USD 24.29M 4.62M Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Henry Schein USD 101M 0 Dec/2025
Idexx Laboratories USD 248.19M 26.42M Dec/2025
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Merck USD 2.96B 2.82B Dec/2025
Nektar Therapeutics USD -37.06M 15.31M Sep/2024
Pacira USD 1.64M 3.8M Dec/2025
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 46.7M 22.44M Dec/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025
Zoetis USD 603M 118M Dec/2025